Spots Global Cancer Trial Database for stage iia pancreatic cancer

Every month we try and update this database with for stage iia pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study	NCT02345460	Pancreatic Aden... Poorly Differen... Resectable Panc... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Undifferentiate...	Irinotecan Hydr... Oxaliplatin Leucovorin Calc... Fluorouracil Laboratory Biom...	18 Years - 75 Years	Case Comprehensive Cancer Center
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery	NCT00305877	Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	cetuximab gemcitabine hyd... capecitabine radiation thera... bevacizumab laboratory biom...	18 Years -	National Cancer Institute (NCI)
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer	NCT01959672	Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con...	19 Years -	University of Nebraska
Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy	NCT02414100	Pancreatic Duct... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre...	Laboratory Biom... Cytology Specim...	18 Years -	Thomas Jefferson University
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer	NCT02349867	Pancreatic Aden... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Recurrent Pancr...	Gemcitabine Sorafenib Vorinostat 3-Dimensional C... Intensity-Modul... RosetteSep DEPfff	18 Years -	Virginia Commonwealth University
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer	NCT01918644	Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	stereotactic bo... capecitabine therapeutic con... magnetic resona... laboratory biom...	19 Years -	University of Wisconsin, Madison
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer	NCT03825289	Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Hydroxychloroqu... Trametinib	18 Years -	University of Utah
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer	NCT01959672	Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con...	19 Years -	University of Nebraska
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery	NCT01416662	Pancreatic Canc...	gemcitabine hyd...	18 Years - 120 Years	Federation Francophone de Cancerologie Digestive
Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer	NCT02307539	Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre...	Psychosocial As... Palliative Ther... Quality-of-Life... Questionnaire A...	21 Years -	City of Hope Medical Center
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer	NCT03825289	Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Hydroxychloroqu... Trametinib	18 Years -	University of Utah
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer	NCT01959672	Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con...	19 Years -	University of Nebraska
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer	NCT01918644	Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	stereotactic bo... capecitabine therapeutic con... magnetic resona... laboratory biom...	19 Years -	University of Wisconsin, Madison
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery	NCT00482625	Intraductal Pap... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	erlotinib hydro... conventional su... immunohistochem... protein express... biopsy pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery	NCT02511821	Stage I Adult L... Stage I Colorec... Stage IA Gastri... Stage IA Pancre... Stage IB Gastri... Stage IB Pancre... Stage II Adult ... Stage IIA Color... Stage IIA Gastr... Stage IIA Pancr... Stage IIB Color... Stage IIB Gastr... Stage IIB Pancr... Stage IIC Color... Stage III Pancr... Stage IIIA Adul... Stage IIIA Colo... Stage IIIA Gast... Stage IIIB Adul... Stage IIIB Colo... Stage IIIB Gast... Stage IIIC Adul... Stage IIIC Colo... Stage IIIC Gast... Stage IV Gastri... Stage IVA Color... Stage IVA Liver... Stage IVA Pancr... Stage IVB Color... Stage IVB Liver... Stage IVB Pancr...	Computer-Assist... Vivofit watch Quality-of-Life... Questionnaire A...	21 Years -	City of Hope Medical Center
Perioperative Therapy for Resectable Pancreatic Cancer	NCT00609336	Adenocarcinoma ... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	gemcitabine hyd... docetaxel capecitabine intensity-modul... oxaliplatin pancreatic surg... therapeutic con... laboratory biom...	18 Years -	University of Washington
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery	NCT00305877	Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	cetuximab gemcitabine hyd... capecitabine radiation thera... bevacizumab laboratory biom...	18 Years -	National Cancer Institute (NCI)
Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer	NCT02307539	Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre...	Psychosocial As... Palliative Ther... Quality-of-Life... Questionnaire A...	21 Years -	City of Hope Medical Center
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer	NCT02349867	Pancreatic Aden... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Recurrent Pancr...	Gemcitabine Sorafenib Vorinostat 3-Dimensional C... Intensity-Modul... RosetteSep DEPfff	18 Years -	Virginia Commonwealth University
Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery	NCT01954732	Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	metformin hydro... pharmacological...	18 Years -	Case Comprehensive Cancer Center
Perioperative Therapy for Resectable Pancreatic Cancer	NCT00609336	Adenocarcinoma ... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	gemcitabine hyd... docetaxel capecitabine intensity-modul... oxaliplatin pancreatic surg... therapeutic con... laboratory biom...	18 Years -	University of Washington
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer	NCT02047474	Acinar Cell Ade... Duct Cell Adeno... Stage I Pancrea... Stage IIA Pancr... Stage IIB Pancr...	oxaliplatin leucovorin calc... irinotecan hydr... fluorouracil therapeutic con... laboratory biom...	18 Years -	Yale University
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery	NCT01416662	Pancreatic Canc...	gemcitabine hyd...	18 Years - 120 Years	Federation Francophone de Cancerologie Digestive
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery	NCT00482625	Intraductal Pap... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	erlotinib hydro... conventional su... immunohistochem... protein express... biopsy pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: